DIABETES TYPE II

Clinical trials for DIABETES TYPE II explained in plain language.

Never miss a new study

Get alerted when new DIABETES TYPE II trials appear

Sign up with your email to follow new studies for DIABETES TYPE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

Can a breast cancer combo be safer for diabetics?

Disease control Not yet recruiting

This trial is testing whether a combination of drugs—inavolisib plus fulvestrant, with or without palbociclib—is safe for people with a specific type of advanced breast cancer (HR+, HER2-negative) that has a PIK3CA mutation, and who also have type 2 diabetes. The main focus is on…

Matched conditions: DIABETES TYPE II

Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC

DIABETES TYPE II

Get alerted when new DIABETES TYPE II trials appear

Can a breast cancer combo be safer for diabetics?